Affiliation:
1. ZONGULDAK BÜLENT ECEVİT ÜNİVERSİTESİ
Abstract
In this study, the electronic properties of the 5-Benzoxazolecarboxylic acid molecule, a benzoxazole derivative, were calculated at the DFT/B3LYP/6-311++G(d,p) level of theory. Electronic properties and chemical reactivity of the optimized structure, such as Frontier molecular orbital (FMO), global and chemical reactivity descriptors, molecular electrostatic potential (MEP), and charge analyses (APT, Hirshfeld, and NBO), were investigated. Also, electronic properties are supported by electron localization function (ELF) and localized orbital locator (LOL) analyses. Toxicity effects such as mutagenic, tumorigenic, irritant, reproductive effect, and physicochemical properties such as druglikeness and drugscore were investigated. Molecular docking studies were conducted with the vascular endothelial growth factor receptor VEGFR-2 and the PARP-2 inhibitor, which is involved in many critical cellular processes, including DNA single-stranded fracture repair and cell death control, and its effectiveness in cancer treatment was investigated.
Publisher
Sakarya University Journal of Science
Reference50 articles.
1. [1] Kamal, K. S. Reddy, M. Naseer, M. J. Ramaiah, “Synthesis, DNA binding ability and anticancer activity of benzthiazole/benzoxazolepyrrolo[2,1-c][1,4]benzodiazepine conjugates,’’ Bioorganic & Medicinal Chemistry Letters, vol.18, pp. 4747-4761, 2010.
2. [2] H. Lage, E. Aki-Sener, I. Yalcin, “High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs,’’ International Journal of Cancer, vol. 119, no.1, pp. 213-220, 2006.
3. [3] M. Arisoy, O. T. Arpaci, F. K. Onurdag, S. Ozgen, “Synthesis and antimicrobial activity of novel benzoxazoles,’’ Zeitschrift für Naturforschung C, vol. 67, no. 9-10, pp. 466-472, 2012.
4. [4] L. Srikanth, R. Jadha, K. Manohar, “Synthesis and evaluation of new phenylamino-thiadiazolo-oxadiazolo-1,3-benzoxazoles for their antifungal and anti-inflammatory activity,’’ Der Pharma Chemica, vol. 2, pp.231-243, 2010.
5. [5] D. N. Ward, D. C. Talley, M. Tavag, S. Menji, P. Schaughency, A. Baier, P. J. Smith, “UK-1 and structural analogs are potent inhibitors of hepatitis C virus replication,’’ Bioorganic & Medicinal Chemistry Letters, vol. 24, no. 2, pp. 609-612, 2014.